Skip to main content
Premium Trial:

Request an Annual Quote

Canon BioMedical Inks Benelux Distribution Deal for Genotyping Assays

NEW YORK (GenomeWeb) – Canon BioMedical said today that it has signed a distribution deal in Benelux for its Novalelle genotyping assays.

Under the agreement, Sanbio, a Netherlands-based distributor that serves the Belgium, the Netherlands, and Luxembourg, will distribute Canon BioMedical's entire portfolio of Novallele assays, controls, and reagents in the region.

The research-use-only Novallele genotyping assays detect genetic variations using PCR followed by high-resolution melting analysis and can be performed on any thermal cycler capable of HRM. The Novallele control sets, including wild-type, heterozygous mutant, and homozygous mutant variants are useful for experiments without an available reference sample, the company noted.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.